Innerer Wert von S&P & Nasdaq Kontaktieren

HeartBeam, Inc. BEATW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
44/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

HeartBeam, Inc. (BEATW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Analysten schätzen Gewinn pro Aktie (EPS) von $-0.73 und Umsatz von $0.00B für das nächste Geschäftsjahr.

Gewinn pro Aktie (EPS) Erfolgsbilanz: 2024: tatsächlich $-0.73 vs Schätzung $-0.73 (übertroffen +0%). 2025: tatsächlich $-0.62 vs Schätzung $-0.61 (verfehlt -1.2%). Analysten-Genauigkeit: 99%.

GpA-Schätzungen — BEATW

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.73 vs Est –$0.73 ▼ 0.0% off
2025 Actual –$0.62 vs Est –$0.61 ▼ 1.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Umsatzschätzungen — BEATW

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Kontaktieren
🎓
SharesGrow Akademie
Lernen Sie inneren Wert zu berechnen und unterbewertete Aktien zu finden.
Wöchentliche Live-Sessions
Nachricht senden